Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, NATCO Pharma has informed that it enclosed the disclosure as per format provided in SEBI Master Circular dated 30th January 2026.
The above information is a part of company’s filings submitted to BSE.